143 related articles for article (PubMed ID: 32026661)
1. The impact of systematic retroperitoneal lymphadenectomy on long-term oncologic outcome of women with advanced ovarian clear-cell carcinoma.
Kajiyama H; Suzuki S; Yoshikawa N; Tamauchi S; Shibata K; Kikkawa F
J Gynecol Oncol; 2020 Jul; 31(4):e47. PubMed ID: 32026661
[TBL] [Abstract][Full Text] [Related]
2. Is standard radical surgery necessary for elderly patients with early-stage epithelial ovarian carcinoma? ~Propensity score matched analysis~.
Kajiyama H; Yoshihara M; Tamauchi S; Yoshikawa N; Niimi K; Suzuki S; Shibata K; Kikkawa F
Jpn J Clin Oncol; 2020 Apr; 50(4):411-418. PubMed ID: 31837651
[TBL] [Abstract][Full Text] [Related]
3. Is there any association between retroperitoneal lymphadenectomy and survival benefit in advanced stage epithelial ovarian carcinoma patients?
Sakai K; Kajiyama H; Umezu T; Shibata K; Mizuno M; Suzuki S; Kawai M; Nagasaka T; Kikkawa F
J Obstet Gynaecol Res; 2012 Jul; 38(7):1018-23. PubMed ID: 22568659
[TBL] [Abstract][Full Text] [Related]
4. Survival benefits of retroperitoneal lymphadenectomy for optimally-resected advanced ovarian high-grade serous carcinoma: a multi-institutional retrospective study.
Ikeda Y; Yoshihara M; Tamauchi S; Yokoi A; Yoshikawa N; Kajiyama H
J Gynecol Oncol; 2022 Jul; 33(4):e40. PubMed ID: 35320889
[TBL] [Abstract][Full Text] [Related]
5. Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysis.
Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Tano S; Matsui S; Kajiyama H
Jpn J Clin Oncol; 2021 Mar; 51(3):387-392. PubMed ID: 33253382
[TBL] [Abstract][Full Text] [Related]
6. Long-term oncologic outcome and its prognostic indicators in reproductive-age women with ovarian clear-cell carcinoma.
Kajiyama H; Suzuki S; Yoshikawa N; Niimi K; Kawai M; Shibata K; Kikkawa F
Arch Gynecol Obstet; 2019 Sep; 300(3):717-724. PubMed ID: 31165243
[TBL] [Abstract][Full Text] [Related]
7. Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer ~propensity score- matched analysis~.
Kajiyama H; Suzuki S; Yoshikawa N; Kawai M; Mizuno K; Yamamuro O; Nagasaka T; Shibata K; Kikkawa F
BMC Cancer; 2019 Dec; 19(1):1235. PubMed ID: 31856753
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis.
Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
Jpn J Clin Oncol; 2020 Feb; 50(2):145-151. PubMed ID: 31688935
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
Song N; Gao Y
Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
[TBL] [Abstract][Full Text] [Related]
10. Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma.
Takei Y; Takahashi S; Machida S; Taneichi A; Yoshiba T; Takahashi Y; Yoshida C; Saga Y; Matsubara S; Fujiwara H
Int J Clin Oncol; 2018 Oct; 23(5):930-935. PubMed ID: 29679177
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
12. Real-world study of lymphadenectomy in patients with advanced epithelial ovarian cancer.
Yin Z; Wang M
J Obstet Gynaecol Res; 2024 Apr; 50(4):663-670. PubMed ID: 38332458
[TBL] [Abstract][Full Text] [Related]
13. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382
[TBL] [Abstract][Full Text] [Related]
14. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.
Panici PB; Maggioni A; Hacker N; Landoni F; Ackermann S; Campagnutta E; Tamussino K; Winter R; Pellegrino A; Greggi S; Angioli R; Manci N; Scambia G; Dell'Anna T; Fossati R; Floriani I; Rossi RS; Grassi R; Favalli G; Raspagliesi F; Giannarelli D; Martella L; Mangioni C
J Natl Cancer Inst; 2005 Apr; 97(8):560-6. PubMed ID: 15840878
[TBL] [Abstract][Full Text] [Related]
15. What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.
Rungruang BJ; Miller A; Krivak TC; Horowitz NS; Rodriguez N; Hamilton CA; Backes FJ; Carson LF; Friedlander M; Mutch DG; Goodheart MJ; Tewari KS; Wenham RM; Bookman MA; Maxwell GL; Richard SD
Cancer; 2017 May; 123(6):985-993. PubMed ID: 27864921
[TBL] [Abstract][Full Text] [Related]
16. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?
Bizzarri N; du Bois A; Fruscio R; De Felice F; De Iaco P; Casarin J; Vizza E; Chiantera V; Corrado G; Cianci S; Magni S; Ferrari D; Giuliani D; Harter P; Ataseven B; Bommert M; Perrone AM; Scambia G; Fagotti A
Gynecol Oncol; 2021 Jan; 160(1):56-63. PubMed ID: 33168305
[TBL] [Abstract][Full Text] [Related]
17. The impact of lymph node dissection on apparent Stage I epithelial ovarian carcinoma: A population-based study.
Chen Q; Wang S; Lang JH
Int J Gynaecol Obstet; 2021 Sep; 154(3):550-557. PubMed ID: 33507544
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients.
Iwase H; Takada T; Iitsuka C; Nomura H; Abe A; Taniguchi T; Takizawa K
J Gynecol Oncol; 2015 Oct; 26(4):303-10. PubMed ID: 26197771
[TBL] [Abstract][Full Text] [Related]
19. The impact of lymphadenectomy on the survival outcomes of ovarian clear cell carcinoma: A retrospective study of the SEER database and Chinese registry.
Liu Y; Zhao W; Huang C; Chu R; Li Z; Wang Y; Song L; Li L
Eur J Surg Oncol; 2024 Mar; 50(3):107975. PubMed ID: 38295548
[TBL] [Abstract][Full Text] [Related]
20. The impact of systematic para-aortic and pelvic lymphadenectomy on survival in patients with optimally debulked ovarian cancer.
Abe A; Furumoto H; Irahara M; Ino H; Kamada M; Naka O; Sasaki M; Kagawa T; Okitsu O; Kushiki N
J Obstet Gynaecol Res; 2010 Oct; 36(5):1023-30. PubMed ID: 21058437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
